Improvement of the safety of a clinical process using failure mode and effects analysis: Prevention of venous thromboembolic disease in critical patients

Med Intensiva. 2016 Nov;40(8):483-490. doi: 10.1016/j.medin.2016.02.003. Epub 2016 Mar 23.
[Article in English, Spanish]

Abstract

Objective: To improve critical patient safety in the prevention of venous thromboembolic disease, using failure mode and effects analysis as safety tool.

Design: A contemporaneous cohort study covering the period January 2014-March 2015 was made in 4 phases: phase 1) prior to failure mode and effects analysis; phase 2) conduction of mode analysis and implementation of the detected improvements; phase 3) evaluation of outcomes, and phase 4) (post-checklist introduction impact.

Setting: Patients admitted to the adult polyvalent ICU of a third-level hospital center.

Patients: A total of 196 patients, older than 18 years, without thromboembolic disease upon admission to the ICU and with no prior anticoagulant treatment.

Interventions: A series of interventions were implemented following mode analysis: training, and introduction of a protocol and checklist to increase preventive measures in relation to thromboembolic disease.

Variables of interest: Indication and prescription of venous thrombosis prevention measures before and after introduction of the measures derived from the failure mode and effects analysis.

Results: A total of 59, 97 and 40 patients were included in phase 1, 3 and 4, respectively, with an analysis of the percentage of subjects who received thromboprophylaxis. The failure mode and effects analysis was used to detect potential errors associated to a lack of training and protocols referred to thromboembolic disease. An awareness-enhancing campaign was developed, with staff training and the adoption of a protocol for the prevention of venous thromboembolic disease. The prescription of preventive measures increased in the phase 3 group (91.7 vs. 71.2%, P=.001). In the post-checklist group, prophylaxis was prescribed in 97.5% of the patients, with an increase in the indication of dual prophylactic measures (4.7, 6.7 and 41%; P<.05). There were no differences in complications rate associated to the increase in prophylactic measures.

Conclusions: The failure mode and effects analysis allowed us to identify improvements in the prevention of thromboembolic disease in critical patients. We therefore consider that it may be a useful tool for improving patient safety in different processes.

Keywords: Análisis modal de fallos y efectos; Critically ill patient; Cuidados intensivos; Enfermedad tromboembólica venosa; Enfermos críticos; Failure mode and effects analysis; Intensive care; Patient safety; Seguridad del paciente; Thromboprophylaxis; Tromboprofilaxis; Venous thromboembolism.

MeSH terms

  • Anticoagulants
  • Checklist
  • Cohort Studies
  • Critical Care
  • Healthcare Failure Mode and Effect Analysis*
  • Hospitalization
  • Humans
  • Venous Thrombosis*

Substances

  • Anticoagulants